Pending regs promote pre-emption
Executive Summary
FDA has inserted pre-emption language into seven proposed rules that have yet to be finalized. FDA first mandated that its labeling pre-empts state requirements in the 2006 physician labeling rule. Similar language is included in a proposed rule on pregnancy and lactation labeling (1"The Pink Sheet" DAILY, May 28, 2008). It is also in proposed rules on skin bleaching drug products, labeling of OTC drugs, OTC analgesics, labeling on calcium claims, labels for sunscreens and a proposed rule on fatty acids. Three of these rules were proposed in 2006 and three in 2007. They must go into effect 60 days before President Bush leaves office
You may also be interested in...
FDA Rule Would Strike “Alphabet Soup” Label Units For Maternal Risks
Proposed rule creates prominent role for registries and a new labeling format that would group risk information into three sections.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.